A political and transparency group, Bauchi Citizens for Good Governance, has called on the Economic and Financial Crimes Commission, EFCC, to broaden its ...

Although MDA gathers experts on an international scale ... but I think it's being able to talk to people at poster sessions and really have those 1-on-1 discussions about research and where ...

Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding ...

Another poster presented at the MDA Clinical & Scientific Conference assessed pooled cardiac outcomes in clinical trials of delandistrogene moxeparvovec with up to 5 years of follow-up data.

Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD).

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...

“This study aligns with previously reported findings and suggests that long-term [treatment with Spinraza] offers sustained clinical benefits in adults with SMA,” researchers wrote in the abstract for ...

The studies were presented in a series of posters at this year’s meeting of the Muscular Dystrophy Association (MDA). Duvyzat is an oral therapy developed by ITF Therapeutics and approved in the U.S.

Several students from the Southern Arkansas University College of Science and Engineering took part in the 108th annual ...